HomeCompareMIRO vs JNJ

MIRO vs JNJ: Dividend Comparison 2026

MIRO yields 59.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MIRO wins by $589.9K in total portfolio value
10 years
MIRO
MIRO
● Live price
59.00%
Share price
$3.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$620.2K
Annual income
$143,088.77
Full MIRO calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — MIRO vs JNJ

📍 MIRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMIROJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MIRO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MIRO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MIRO
Annual income on $10K today (after 15% tax)
$5,014.75/yr
After 10yr DRIP, annual income (after tax)
$121,625.45/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, MIRO beats the other by $117,639.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MIRO + JNJ for your $10,000?

MIRO: 50%JNJ: 50%
100% JNJ50/50100% MIRO
Portfolio after 10yr
$325.2K
Annual income
$73,889.08/yr
Blended yield
22.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MIRO
Analyst Ratings
2
Buy
Consensus: Buy
Price Target
$9.00
+165.5% upside vs current
Range: $9.00 — $9.00
Altman Z
-3.6
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MIRO buys
0
JNJ buys
0
No recent congressional trades found for MIRO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMIROJNJ
Forward yield59.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$620.2K$30.3K
Annual income after 10y$143,088.77$4,689.40
Total dividends collected$512.6K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$9.00$228.73

Year-by-year: MIRO vs JNJ ($10,000, DRIP)

YearMIRO PortfolioMIRO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$16,600$5,899.71$10,592$272.30+$6.0KMIRO
2$26,914$9,152.65$11,289$357.73+$15.6KMIRO
3$42,667$13,869.04$12,123$472.89+$30.5KMIRO
4$66,202$20,548.25$13,141$629.86+$53.1KMIRO
5$100,633$29,796.73$14,408$846.81+$86.2KMIRO
6$150,008$42,330.45$16,021$1,151.60+$134.0KMIRO
7$219,480$58,971.49$18,122$1,588.22+$201.4KMIRO
8$315,482$80,637.85$20,930$2,228.20+$294.6KMIRO
9$445,892$108,326.32$24,792$3,191.91+$421.1KMIRO
10$620,193$143,088.77$30,274$4,689.40+$589.9KMIRO

MIRO vs JNJ: Complete Analysis 2026

MIROStock

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Full MIRO Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MIRO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MIRO vs SCHDMIRO vs JEPIMIRO vs OMIRO vs KOMIRO vs MAINMIRO vs ABBVMIRO vs MRKMIRO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.